BPC-157 + TB-500: The Healing Combo
The most common peptide pairing in the healing space. Two compounds, two mechanisms, one goal: faster recovery from soft-tissue injuries. Mechanistically complementary; human RCTs pending.
How It Works
Angiogenesis — new blood vessels into damaged tissue. VEGFR2 upregulation. Nitric oxide modulation. Growth factor expression. The 'bring nutrients to the injury' half.
Actin-binding fragment of Thymosin Beta-4. Releases actin monomers so cells can reshape and migrate toward injured tissue. The 'send rebuild crews' half.
BPC-157 provides infrastructure (vasculature); TB-500 moves rebuild cells (fibroblasts, endothelial cells, stem cells) to the work site. Pathways are distinct, so no mechanistic redundancy.
No head-to-head human RCT comparing the stack to either compound alone. User reports are the main evidence for combined efficacy. The mechanism is defensible; the incremental human benefit is still inferred.
What the Data Shows
Daily Dosing Schedule
Key Takeaways
- Mechanisms are distinct — angiogenesis (BPC-157) + cell migration (TB-500)
- Animal evidence for each compound individually is strong
- Most common stack in injury-recovery user reports
- Standard cycle is 8-12 weeks
- Well-tolerated at standard doses in reported use
- No head-to-head human RCT for the stack vs single compound
- Long-term safety data for the combination specifically is thin
- Angiogenesis + cell-migration = theoretical cancer caution
- Not suitable during pregnancy / lactation
- WADA-prohibited for athletes
Frequently Asked Questions
Can I run just one instead of both?
Yes — BPC-157 alone is a defensible starting point, especially for acute injuries. TB-500 alone is less common but used for specific cell-migration-relevant issues. Most users who run the stack could get meaningful benefit from BPC-157 alone; they add TB-500 when the injury is complex or recovery stalls.
Timing of injections?
BPC-157: split morning/evening. TB-500: often done pre-workout or pre-sleep. No strict timing requirement — consistency matters more than precise timing.
Can I use this for chronic pain vs acute injury?
Both. Acute injuries tend to respond faster (2-6 weeks). Chronic issues (old injuries, tendinopathy) often need the full 8-12 week cycle. Chronic OA pain is the most variable — results range from dramatic to minimal.
Is 2x weekly enough for TB-500?
Yes — TB-500's half-life is long enough that 2x/week SC injection maintains therapeutic levels. Some protocols use 2.5mg 2x/week during loading, then drop to 2mg weekly during maintenance.
🔬 Research-Grade Source
Swiss Chems publishes third-party HPLC COAs for every batch. HighPeptides' primary vendor reference for peptides.
Browse Swiss Chems →Affiliate link — supports HighPeptides at no extra cost
🛒 Recommended Products
Support supplements and gear relevant to this protocol.
Affiliate links — support HighPeptides at no extra cost.
BPC-157 and TB-500 are research-use-only compounds — not FDA-approved for human consumption. The stack protocols described are based on animal research and user reports.
Both are WADA-prohibited substances. Not medical advice. Research use only.